Novel insulin sensitizers: pharmacogenomic aspects

By Otto Carsten   Lehrke Michael   Göke Burkhard  

Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. : 99-116

Future Medicine

Access to resources Recommend Favorite

Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle

By Eto K.   Ohya Y.   Nakamura Y.   Abe I.   Fujishima M.  

European Journal of Pharmacology, Vol. 423, Iss. 1, 2001-06 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes

By Knock G.A.   Mishra S.K.   Aaronson P.I.  

European Journal of Pharmacology, Vol. 368, Iss. 1, 1999-02 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite

Modulation of metabolic and cardiac dysfunctions by insulin sensitizers and angiotensin receptor blocker in rat model of type 2 diabetes mellitus

By Hussein Abd El-Aziz M.   Omar Nisereen M.   Sakr Hussein   Elsamanoudy Ayman Z.   Shaheen Dalia  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 3, 2011-03 ,pp. : 216-226

NRC Research Press

Access to resources Recommend Favorite

Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases

By Colca Jerry R   Tanis Steven P   McDonald William G   Kletzien Rolf F  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite